On July 22, WuXi AppTec (02359.HK) rose 3.16% in regular trading, trading at 163.6 HKD/share, with turnover of 243 million HKD. The stock gained momentum as multiple international investment banks issued upgraded target prices in a coordinated bullish stance.

On the news front, UBS raised its target price to 176.5 HKD and designated WuXi AppTec as its sector top pick. Daiwa significantly lifted its target to 190 HKD, while Morgan Stanley raised its target to 168 HKD and reaffirmed the company as a preferred stock, upgrading earnings forecasts for fiscal years through 2028 by 4%-6%, implying a 16% CAGR from 2025 to 2028.

Fundamentally, the company reported Q1 backlog orders reaching 59.77 billion yuan, up 23.6% year-over-year. Its TIDES business saw client numbers and molecules served grow 28% and 59% respectively, with full-year TIDES revenue growth projected at approximately 40%. The broader CXO sector continues to rally on robust orders and earnings support, with peers Pharmaron up 6.1%, JOINN up 5.16%, and Insilico up 6.42% in today's session.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)